Open AccessHand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
Author(s) -
Chikara Ogawa,
Masahiro Morita,
Akina Omura,
Teruyo Noda,
Atsushi Kubo,
Toshihiro Matsunaka,
Hiroyuki Tamaki,
Mitsushige Shibatoge,
Akemi Tsutsui,
Tomonori Senoh,
Takuya Nagano,
Kouichi Takaguchi,
Joji Tani,
Asahiro Morishita,
Hirohito Yoneyama,
Tsutomu Masaki,
Akio Moriya,
Masaharu Ando,
Akihiro Deguchi,
Yasutaka Kokudo,
Yasunori Minami,
Kazuomi Ueshima,
Toshiharu Sakurai,
Naoshi Nishida,
Masatoshi Kudo
Publication year - 2017
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000481241
Subject(s) - sorafenib , hepatocellular carcinoma , medicine , gastroenterology
To determine the relationship between treatment outcomes and hand-foot syndrome (HFS), and the relationship between survival rate and post-progression treatment after sorafenib therapy.